Ekso Selling And Marketing Expenses vs Reconciled Depreciation Analysis
EKSO Stock | USD 1.45 0.09 6.62% |
Ekso Bionics financial indicator trend analysis is much more than just examining Ekso Bionics Holdings latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ekso Bionics Holdings is a good investment. Please check the relationship between Ekso Bionics Selling And Marketing Expenses and its Reconciled Depreciation accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Selling And Marketing Expenses vs Reconciled Depreciation
Selling And Marketing Expenses vs Reconciled Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ekso Bionics Holdings Selling And Marketing Expenses account and Reconciled Depreciation. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Ekso Bionics' Selling And Marketing Expenses and Reconciled Depreciation is 0.11. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Ekso Bionics Holdings, assuming nothing else is changed. The correlation between historical values of Ekso Bionics' Selling And Marketing Expenses and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Ekso Bionics Holdings are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Selling And Marketing Expenses i.e., Ekso Bionics' Selling And Marketing Expenses and Reconciled Depreciation go up and down completely randomly.
Correlation Coefficient | 0.11 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Selling And Marketing Expenses
Reconciled Depreciation
Most indicators from Ekso Bionics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ekso Bionics Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. As of the 16th of May 2024, Sales General And Administrative To Revenue is likely to grow to 1.01, while Selling General Administrative is likely to drop about 8.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.7M | 6.2M | 9.7M | 5.1M | Total Revenue | 11.2M | 12.9M | 18.3M | 12.3M |
Ekso Bionics fundamental ratios Correlations
Click cells to compare fundamentals
Ekso Bionics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ekso Bionics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 21.9M | 20.6M | 49.2M | 40.9M | 28.9M | 26.0M | |
Short Long Term Debt Total | 3.9M | 3.9M | 2.2M | 7.5M | 7.2M | 3.7M | |
Other Current Liab | 1.7M | 1.4M | 2.3M | 2.3M | 2.7M | 2.3M | |
Total Current Liabilities | 7.8M | 5.0M | 6.9M | 9.2M | 8.1M | 6.6M | |
Total Stockholder Equity | 6.8M | 4.4M | 37.2M | 25.4M | 12.6M | 13.6M | |
Net Debt | (7M) | (9.0M) | (38.2M) | (13.0M) | (1.5M) | (1.5M) | |
Retained Earnings | (183.3M) | (199.1M) | (208.9M) | (223.9M) | (239.1M) | (227.2M) | |
Cash | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 16.1M | |
Cash And Short Term Investments | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 8.2M | |
Common Stock Total Equity | 60K | 63K | 87K | 8K | 9.2K | 8.7K | |
Liabilities And Stockholders Equity | 21.9M | 20.6M | 49.2M | 40.9M | 28.9M | 26.0M | |
Non Current Liabilities Total | 7.3M | 11.2M | 5.1M | 6.3M | 8.2M | 7.4M | |
Total Liab | 15.1M | 16.2M | 11.9M | 15.5M | 16.3M | 13.4M | |
Total Current Assets | 18.8M | 18.4M | 47.8M | 31.0M | 20.2M | 22.1M | |
Short Term Debt | 2.8M | 548K | 229K | 2.7M | 1.6M | 1.1M | |
Common Stock | 63K | 87K | 8K | 13K | 15K | 14.3K | |
Common Stock Shares Outstanding | 4.8M | 7.2M | 12.3M | 13.0M | 13.9M | 14.6M | |
Other Stockholder Equity | 189.9M | 204.4M | 246.1M | 248.8M | 251.6M | 179.6M | |
Other Liab | 6.2M | 7.9M | 3.1M | 1.4M | 1.3M | 1.2M | |
Net Tangible Assets | 6.6M | 4.4M | 37.2M | 19.8M | 22.8M | 15.5M | |
Property Plant And Equipment Net | 2.7M | 1.9M | 1.2M | 4.0M | 3.0M | 2.7M | |
Current Deferred Revenue | 1.5M | 1.5M | 1.2M | 1.1M | 2.0M | 1.4M | |
Accounts Payable | 1.9M | 1.5M | 3.1M | 3.2M | 1.8M | 2.5M | |
Non Current Assets Total | 3.1M | 2.2M | 1.4M | 9.9M | 8.7M | 5.0M | |
Non Currrent Assets Other | 178K | 320K | 164K | 231K | 392K | 504.2K | |
Other Assets | 134K | 178K | 1.0M | 164K | 147.6K | 140.2K | |
Long Term Debt | 407K | 9.1M | 2.0M | 3.8M | 4.8M | 3.8M | |
Net Receivables | 5.2M | 3.4M | 4.7M | 4.6M | 5.6M | 3.9M | |
Long Term Debt Total | 4.8M | 2.6M | 407K | 9.1M | 10.5M | 11.0M | |
Capital Surpluse | 165.8M | 173.9M | 189.9M | 204.4M | 235.0M | 165.0M | |
Inventory | 2.5M | 2.0M | 2.2M | 5.2M | 5.1M | 2.9M | |
Other Current Assets | 238K | 191K | 485K | 700K | 875K | 597.9K | |
Property Plant And Equipment Gross | 2.7M | 1.9M | 1.2M | 4.0M | 6.2M | 6.5M | |
Accumulated Other Comprehensive Income | 50K | (847K) | (17K) | 563K | 156K | 163.8K | |
Property Plant Equipment | 2.7M | 1.2M | 1.2M | 4.0M | 4.6M | 2.6M |
Pair Trading with Ekso Bionics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.Moving together with Ekso Stock
0.61 | NPCE | Neuropace Downward Rally | PairCorr |
Moving against Ekso Stock
0.78 | SGHT | Sight Sciences | PairCorr |
0.65 | CGC | Canopy Growth Corp Upward Rally | PairCorr |
0.61 | ACB | Aurora Cannabis Buyout Trend | PairCorr |
0.52 | ATNFW | CannBioRx Life Sciences | PairCorr |
0.5 | CRON | Cronos Group Buyout Trend | PairCorr |
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Ekso Stock analysis
When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Revenue Per Share 1.202 | Quarterly Revenue Growth (0.09) | Return On Assets (0.26) | Return On Equity (0.81) |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.